Index
S&P 500
Market Cap
11.67B
Enterprise Value
17.82B
Income
1.46B
Sales
18.35B
Book/sh
127.49
Cash/sh
2.86
Employees
101500
IPO
Jul 09, 1981
P/E
8.28
Forward P/E
8.54
PEG
1.73
P/S
0.64
P/B
1.55
P/C
69.14
P/FCF
10.46
EV/EBITDA
6.72
EV/Sales
0.97
Quick Ratio
1.28
Current Ratio
1.37
Debt/Eq
0.81
LT Debt/Eq
0.79
Option/Short
Yes / Yes
EPS (ttm)
23.92
EPS next Y
23.18
EPS next Q
5.66
EPS this Y
3.34%
EPS next Y
3.20%
EPS next 5Y
4.93%
EPS past 3/5Y
36.20% 15.93%
Sales past 3/5Y
9.03% 8.48%
EPS Y/Y TTM
13.14%
Sales Y/Y TTM
8.00%
EPS Q/Q
-10.90%
Sales Q/Q
5.30%
Insider Own
17.21%
Insider Trans
0.00%
Inst Own
93.30%
Inst Trans
-0.46%
ROA
8.99%
ROE
19.80%
ROIC
10.74%
Gross Margin
10.85%
Oper. Margin
10.85%
Profit Margin
7.96%
SMA20
8.21%
SMA50
11.14%
SMA200
12.05%
Trades
Shs Outstand
58.94M
Shs Float
48.79M
52W High
246.32 -19.62%
52W Low
140.08 41.35%
Volatility
4.21% 3.49%
ATR (14)
7.50
RSI (14)
65.74
Beta
1.11
Rel Volume
1.26
Avg Volume
700.53K
Volume
748,241
Perf Week
12.11%
Perf Month
13.39%
Perf Quarter
14.09%
Perf Half Y
16.09%
Perf YTD
-9.18%
Perf Year
-13.14%
Perf 3Y
54.39%
Perf 5Y
52.45%
Perf 10Y
64.52%
Prev Close
196.46
Price
198.00
Change %
0.78%
Analysts 12 incl. previous ratings
Rating Distribution 3 Buy · 8 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jul 08, 2026 Downgrade B Barclays
Overweight → Equal Weight $179 -9.6% Jun 01, 2026 Resumed W Wells Fargo
Equal Weight $165 -16.7% Apr 29, 2026 Downgrade R Raymond James
Outperform → Mkt Perform Jan 07, 2026 Downgrade W Wells Fargo
Overweight → Equal Weight $235 +18.7% Nov 03, 2025 Upgrade R Raymond James
Mkt Perform → Outperform $270 +36.4% Oct 14, 2025 Resumed G Goldman
Neutral $219 +10.6% Jul 16, 2025 Downgrade B BofA Securities
Neutral → Underperform $185 -6.6% Apr 15, 2025 Downgrade R Robert W. Baird
Outperform → Neutral $224 +13.1% Mar 26, 2025 Initiated M Morgan Stanley
Equal-Weight $200 +1.0% Feb 03, 2025 Upgrade C Cantor Fitzgerald
Neutral → Overweight Dec 17, 2024 Resumed J JP Morgan
Neutral $226 +14.1% Dec 16, 2024 Downgrade G Goldman
Buy → Neutral $228 → $198 0.0% Nov 06, 2024 Resumed B BofA Securities
Neutral $223 +12.6% Oct 16, 2024 Upgrade T TD Cowen
Hold → Buy $220 → $283 +42.9% Oct 11, 2024 Initiated K KeyBanc Capital Markets
Sector Weight Jul 26, 2024 Upgrade C Cantor Fitzgerald
Underweight → Neutral $162 → $219 +10.6% Jul 26, 2024 Upgrade B Barclays
Equal Weight → Overweight $256 +29.3% Jun 26, 2024 Upgrade R Robert W. Baird
Neutral → Outperform $198 → $236 +19.2% May 30, 2024 Initiated R Robert W. Baird
Neutral $198 0.0% May 20, 2024 Upgrade U UBS
Neutral → Buy $189 → $226 +14.1%
Show Previous Ratings
Nov-04-26 01:16PM
12:19PM
10:06AM
Nov-03-26 10:13AM
Nov-01-26 05:30AM
(The Wall Street Journal)
04:09PM
Loading…
Oct-30-26 04:09PM
Oct-29-26 11:14AM
Oct-28-26 02:36PM
11:04AM
Oct-27-26 06:26PM
04:16PM
Oct-09-26 04:05PM
Oct-05-26 04:05PM
Aug-25-26 05:15PM
Aug-17-26 08:52AM
04:05AM
Loading…
04:05AM
Jul-29-26 06:40AM
Jul-28-26 05:01PM
Jul-27-26 04:28PM
04:16PM
Jul-15-26 04:20PM
Jul-14-26 04:30PM
Jul-08-26 09:39AM
08:12AM
Jul-06-26 04:15PM
Jun-24-26 03:09PM
Jun-11-26 07:04PM
May-28-26 05:04AM
May-27-26 04:15PM
04:10PM
04:15PM
Loading…
Apr-30-26 04:15PM
Apr-29-26 09:42AM
03:06AM
Apr-27-26 04:21PM
(Associated Press)
-9.45%
04:15PM
Apr-06-26 04:14PM
Apr-01-26 09:46AM
Mar-26-26 08:41AM
Mar-10-26 01:18PM
Mar-09-26 09:05AM
07:39AM
04:55AM
Mar-08-26 07:27AM
Mar-05-26 09:56AM
Mar-04-26 09:04AM
12:48AM
Mar-03-26 10:36PM
09:45AM
Mar-02-26 09:50AM
Feb-28-26 11:09PM
Feb-27-26 12:43PM
10:05AM
06:21AM
06:17AM
Feb-26-26 04:34PM
12:28PM
12:25PM
11:21AM
10:17AM
Feb-25-26 08:30PM
08:05PM
04:42PM
(Associated Press Finance)
04:36PM
04:16PM
Feb-23-26 10:17PM
Feb-20-26 12:08PM
09:15AM
Feb-19-26 09:40AM
08:05AM
Feb-18-26 05:45PM
Feb-17-26 11:03PM
06:13PM
04:15PM
Feb-16-26 09:40AM
Feb-15-26 11:03PM
Feb-12-26 04:15PM
Feb-06-26 09:21AM
Feb-03-26 10:26AM
Feb-02-26 04:10PM
12:45PM
08:57AM
06:14AM
Jan-30-26 11:30AM
09:40AM
Jan-28-26 01:13PM
Jan-27-26 12:10PM
11:52AM
Jan-22-26 12:27PM
09:38AM
Jan-21-26 10:06AM
07:08AM
Jan-20-26 03:00PM
08:00AM
Jan-16-26 12:45PM
Jan-15-26 10:08AM
Jan-14-26 09:40AM
08:52AM
Jan-13-26 11:19AM
09:45AM
Jan-12-26 09:40AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Singer Maria Ruderman Director Mar 12 '26 Option Exercise 138.80 2,500 347,000 10,384 Mar 13 04:48 PM Miller Marc D President and CEO Mar 12 '26 Option Exercise 145.77 100,425 14,638,889 411,721 Mar 13 04:32 PM FILTON STEVE Executive Vice President & CFO Mar 12 '26 Option Exercise 146.14 83,237 12,164,529 201,738 Mar 13 04:29 PM SUSSMAN ELLIOT J MD MBA Director Mar 13 '26 Option Exercise 138.80 1,250 173,500 7,363 Mar 13 04:11 PM SUSSMAN ELLIOT J MD MBA Director Mar 11 '26 Option Exercise 138.80 1,250 173,500 7,363 Mar 13 04:11 PM SUSSMAN ELLIOT J MD MBA Director Mar 13 '26 Sale 193.37 356 68,841 6,113 Mar 13 04:11 PM SUSSMAN ELLIOT J MD MBA Director Mar 11 '26 Sale 186.35 318 59,258 6,113 Mar 13 04:11 PM ELLIOT SUSSMAN Director Mar 13 '26 Proposed Sale 193.37 356 68,841 Mar 13 04:06 PM ELLIOT SUSSMAN Director Mar 11 '26 Proposed Sale 186.35 318 59,258 Mar 11 04:55 PM MILLER ALAN B Executive Chairman Mar 10 '26 Option Exercise 146.14 132,712 19,394,968 1,878,743 Mar 11 04:06 PM WARREN NIMETZ Director Nov 11 '25 Proposed Sale 223.30 3,817 852,343 Nov 12 09:10 AM Nimetz Warren J. Director Nov 11 '25 Option Exercise 138.80 10,000 1,388,000 18,481 Nov 12 08:24 AM Nimetz Warren J. Director Nov 11 '25 Sale 223.30 3,817 852,343 8,481 Nov 12 08:24 AM
Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.
Founder & Executive Chairman of the Board Mr. Alan B. Miller
CEO Mr. Marc D. Miller
Executive VP Mr. Steve G. Filton
Executive VP & President of Acute Care Division Mr. Edward H. Sim
Vice President of Investor Relations Mr. Darren P. Lehrich